Soluble human endothelin-converting enzyme-1: Expression, purification, and demonstration of pronounced pH sensitivity

被引:33
作者
Ahn, K [1 ]
Herman, SB [1 ]
Fahnoe, DC [1 ]
机构
[1] Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Dept Biochem, Ann Arbor, MI 48105 USA
关键词
soluble endothelin-converting enzyme-1; endothelin; pH sensitivity; glycosylation;
D O I
10.1006/abbi.1998.0913
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endothelin-converting enzyme-1 (ECE-1) is a type II integral membrane protein that belongs to a family of metalloproteases which includes ECE-S, neprilysin (neutral endopeptidase 24.11, EC 3.4.24.11), and Kell blood group protein. ECE-1 cleaves its biologically inactive native substrate, big endothelin-l, to generate a powerful vasoactive 21-amino acid peptide, endothelin-1. ECE-1 consists of a short N-terminal cytoplasmic tail, a transmembrane hydrophobic domain, and a large extracellular domain containing the catalytic site with a conserved Zn-binding motif. We have constructed a secreted, soluble form of ECE-1 (solECE-1) by fusing the cleavable N-terminal signal sequence of human alkaline phosphatase in frame with the entire extracellular domain of ECE-1. Stable transfectant CHO cell lines expressing up to 6.1 mg of solECE-1 per liter culture medium were established and solECE-1 was purified to homogeneity using three chromatographic steps with a 24% yield. SolECE-1 behaves as a dimer of 110-kDa subunits. SolECE-1 has a sharp pH optimum, similar to the native form, ECE-la, but has a slightly more acidic pH optimum of 6.1-6.4 than that of 6.7-6.9 for ECE-la. At its optimal pH of 6.4, solECE-1 cleaved big ET-l:big ET-a:big ET-3 in a ratio of 8.1:1:1.4, was inhibited by phosphoramidon with an IC50 value of 0.35 +/- 0.05 mu M had a K-m value of 4.65 +/- 0.78 mu M for big ET-1, and had a k(cat) value of 5.82 +/- 0.21 min(-1), all values comparable to those for ECE-la at its optimal pH of 6.8. Phosphoramidon inhibition of both ECE-la and solECE-1 is highly pH-dependent. At pH 5.8, phosphoramidon inhibited ECE-la and solECE-1 with IC,, values of 14 and 33 nM, respectively, which are 49- and 1224-fold more potent than at pH 7.2. SolECE-1 is highly glycosylated, similar to ECE-la. Deglycosylation of solECE-1 by peptide N-glycosidase F shifted the apparent molecular weight of solECE-1 to approximately 80 kDa and the deglycosylated form(s) of solECE-1 preserved at least 72% of the activity of the glycosylated form. (C) 1998 Academic Press.
引用
收藏
页码:258 / 268
页数:11
相关论文
共 46 条
  • [1] Ahn K, 1996, BIOCHEM MOL BIOL INT, V39, P573
  • [2] Novel selective quinazoline inhibitors of endothelin converting enzyme-1
    Ahn, K
    Sisneros, AM
    Herman, SB
    Pan, SM
    Hupe, D
    Lee, C
    Nikam, S
    Cheng, XM
    Doherty, AM
    Schroeder, RL
    Haleen, SJ
    Kaw, S
    Emoto, N
    Yanagisawa, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 243 (01) : 184 - 190
  • [3] THE ENDOTHELIN-CONVERTING ENZYME FROM HUMAN UMBILICAL VEIN IS A MEMBRANE-BOUND METALLOPROTEASE SIMILAR TO THAT FROM BOVINE AORTIC ENDOTHELIAL-CELLS
    AHN, K
    BENINGO, K
    OLDS, G
    HUPE, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (18) : 8606 - 8610
  • [4] A PERMANENT HUMAN CELL-LINE (EA.HY926) PRESERVES THE CHARACTERISTICS OF ENDOTHELIN-CONVERTING ENZYME FROM PRIMARY HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS
    AHN, K
    PAN, S
    BENINGO, K
    HUPE, D
    [J]. LIFE SCIENCES, 1995, 56 (26) : 2331 - 2341
  • [5] AHN K, 1998, HDB PROTEOLYTIC ENZY, P1085
  • [6] INTERACTION OF ENDOTHELIN-3 WITH ENDOTHELIN-B RECEPTOR IS ESSENTIAL FOR DEVELOPMENT OF EPIDERMAL MELANOCYTES AND ENTERIC NEURONS
    BAYNASH, AG
    HOSODA, K
    GIAID, A
    RICHARDSON, JA
    EMOTO, N
    HAMMER, RE
    YANAGISAWA, M
    [J]. CELL, 1994, 79 (07) : 1277 - 1285
  • [7] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [8] Endothelin inhibitors
    Cheng, XM
    Ahn, K
    Haleen, SJ
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 32, 1997, 32 : 61 - 70
  • [9] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [10] PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN REVEALED BY THE 1ST ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST
    CLOZEL, M
    BREU, V
    BURRI, K
    CASSAL, JM
    FISCHLI, W
    GRAY, GA
    HIRTH, G
    LOFFLER, BM
    MULLER, M
    NEIDHART, W
    RAMUZ, H
    [J]. NATURE, 1993, 365 (6448) : 759 - 761